Clinical Trial Update: Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating thalidomide in combination with SU5416 for metastatic melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• SU5416 (semaxanib)
• Thalidomide (thalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED